313 related articles for article (PubMed ID: 26485069)
1. The ins and outs of selective kinase inhibitor development.
Müller S; Chaikuad A; Gray NS; Knapp S
Nat Chem Biol; 2015 Nov; 11(11):818-21. PubMed ID: 26485069
[No Abstract] [Full Text] [Related]
2. Properties of FDA-approved small molecule protein kinase inhibitors.
Roskoski R
Pharmacol Res; 2019 Jun; 144():19-50. PubMed ID: 30877063
[TBL] [Abstract][Full Text] [Related]
3. Protocols for the Design of Kinase-focused Compound Libraries.
Jacoby E; Wroblowski B; Buyck C; Neefs JM; Meyer C; Cummings MD; van Vlijmen H
Mol Inform; 2018 May; 37(5):e1700119. PubMed ID: 29116686
[TBL] [Abstract][Full Text] [Related]
4. Discovery of inter-domain stabilizers-a novel assay system for allosteric akt inhibitors.
Fang Z; Simard JR; Plenker D; Nguyen HD; Phan T; Wolle P; Baumeister S; Rauh D
ACS Chem Biol; 2015 Jan; 10(1):279-88. PubMed ID: 24959717
[TBL] [Abstract][Full Text] [Related]
5. Application of Free-Wilson selectivity analysis for combinatorial library design.
Sciabola S; Stanton RV; Johnson TL; Xi H
Methods Mol Biol; 2011; 685():91-109. PubMed ID: 20981520
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors paradoxically prime kinases.
Frye SV; Johnson GL
Nat Chem Biol; 2009 Jul; 5(7):448-9. PubMed ID: 19465930
[No Abstract] [Full Text] [Related]
7. Fragment-based approaches to the discovery of kinase inhibitors.
Mortenson PN; Berdini V; O'Reilly M
Methods Enzymol; 2014; 548():69-92. PubMed ID: 25399642
[TBL] [Abstract][Full Text] [Related]
8. Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: a template-based approach--part 1.
Dwyer MP; Paruch K; Labroli M; Alvarez C; Keertikar KM; Poker C; Rossman R; Fischmann TO; Duca JS; Madison V; Parry D; Davis N; Seghezzi W; Wiswell D; Guzi TJ
Bioorg Med Chem Lett; 2011 Jan; 21(1):467-70. PubMed ID: 21094608
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of 2-phenylisothiazolidin-3-one-1,1-dioxides as a new class of human protein kinase CK2 inhibitors.
Chekanov MO; Ostrynska OV; Synyugin AR; Bdzhola VG; Yarmoluk SM
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):338-43. PubMed ID: 23578312
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation, and molecular modeling of natural and unnatural flavonoidal alkaloids, inhibitors of kinases.
Nguyen TB; Lozach O; Surpateanu G; Wang Q; Retailleau P; Iorga BI; Meijer L; Guéritte F
J Med Chem; 2012 Mar; 55(6):2811-9. PubMed ID: 22352892
[TBL] [Abstract][Full Text] [Related]
11. Toward a pharmacophore for kinase frequent hitters.
Aronov AM; Murcko MA
J Med Chem; 2004 Nov; 47(23):5616-9. PubMed ID: 15509160
[TBL] [Abstract][Full Text] [Related]
12. Assessing protein kinase target similarity: Comparing sequence, structure, and cheminformatics approaches.
Gani OA; Thakkar B; Narayanan D; Alam KA; Kyomuhendo P; Rothweiler U; Tello-Franco V; Engh RA
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1605-16. PubMed ID: 26001898
[TBL] [Abstract][Full Text] [Related]
13. Redefining the Protein Kinase Conformational Space with Machine Learning.
Ung PM; Rahman R; Schlessinger A
Cell Chem Biol; 2018 Jul; 25(7):916-924.e2. PubMed ID: 29861272
[TBL] [Abstract][Full Text] [Related]
14. Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: a template-based approach--part 2.
Labroli M; Paruch K; Dwyer MP; Alvarez C; Keertikar K; Poker C; Rossman R; Duca JS; Fischmann TO; Madison V; Parry D; Davis N; Seghezzi W; Wiswell D; Guzi TJ
Bioorg Med Chem Lett; 2011 Jan; 21(1):471-4. PubMed ID: 21094607
[TBL] [Abstract][Full Text] [Related]
15. Fragment-based discovery of JAK-2 inhibitors.
Antonysamy S; Hirst G; Park F; Sprengeler P; Stappenbeck F; Steensma R; Wilson M; Wong M
Bioorg Med Chem Lett; 2009 Jan; 19(1):279-82. PubMed ID: 19019674
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomics of kinase inhibitor targets and mechanisms.
Daub H
ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
[TBL] [Abstract][Full Text] [Related]
17. Design and Analysis of the 4-Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure-Activity Relationships.
Asquith CRM; Laitinen T; Bennett JM; Wells CI; Elkins JM; Zuercher WJ; Tizzard GJ; Poso A
ChemMedChem; 2020 Jan; 15(1):26-49. PubMed ID: 31675459
[TBL] [Abstract][Full Text] [Related]
18. Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors.
Verkhivker GM
Curr Med Chem; 2017; 24(42):4838-4872. PubMed ID: 27719654
[TBL] [Abstract][Full Text] [Related]
19. The design, annotation, and application of a kinase-targeted library.
Xi H; Lunney EA
Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
[TBL] [Abstract][Full Text] [Related]
20. Lessons learned from molecular scaffold analysis.
Hu Y; Stumpfe D; Bajorath J
J Chem Inf Model; 2011 Aug; 51(8):1742-53. PubMed ID: 21755989
[No Abstract] [Full Text] [Related]
[Next] [New Search]
